← Open Payments lookup

HANITA CHHABRA: Open Payments

NPI 1669552428 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$280 in 13 payments from 9 companies in 2025. Trend: 2023 $188 · 2024 $88 · 2025 $280

Food & beverage: $280
CompanyPaymentsAmount
Otsuka Pharmaceutical Development & Commercialization, Inc.2$53
ABBVIE INC.2$45
Teva Pharmaceuticals USA, Inc.2$37
Lundbeck LLC2$34
Neurocrine BioSciences, Inc.1$32
Bausch Health US, LLC1$23
Supernus Pharmaceuticals, Inc.1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
TMS NeuroHealth Centers Inc.1$17

Products named: VRAYLAR, AUSTEDO XR, REXULTI, INGREZZA, WELLBUTRIN, Qelbree, CAPLYTA, TMS NeuroHealth Centers Inc..

Industry payments across MD — which companies pay providers there.